NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
REBN
Reborn Coffee, Inc.
There isn't enough reported data to score REBN yet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
REBN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
REBN's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
REBN PE Valuation
REBN has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
REBN Forward outlook
There aren't enough analyst estimates for REBN to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO has the edge over REBN on earnings, with more consistent year-over-year improvement.
REBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.65 | +$1.55 |
| Q1 2026 | -$1.48 | +$0.05 |
| Q4 2025 | -$1.73 | -$0.07 |
| Q3 2025 | -$2.58 | -$0.23 |
| Q2 2025 | -$2.20 | +$0.33 |
| Q1 2025 | -$1.53 | +$1.32 |
| Q4 2024 | -$1.66 | +$1.23 |
| Q3 2024 | -$2.35 | +$0.35 |
REBN is still losing money, but far less than before: $0.65 per share over the past year, against $2.89 at its worst in late 2023.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over REBN on profitability, with a higher operating margin.
REBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.3M | +245% |
| Q1 2026 | $5.2M | +208% |
| Q4 2025 | $3.2M | +80% |
| Q3 2025 | $1.4M | +7.8% |
| Q2 2025 | $1.8M | +34% |
| Q1 2025 | $1.7M | +12% |
| Q4 2024 | $1.8M | +31% |
| Q3 2024 | $1.3M | -17% |
REBN has the edge over NIO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -25% | +215 points |
| Q1 2026 | -17% | +84 points |
| Q4 2025 | 105% | +200 points |
| Q3 2025 | -225% | -167 points |
| Q2 2025 | -240% | -143 points |
| Q1 2025 | -100% | -43 points |
| Q4 2024 | -95% | +27 points |
| Q3 2024 | -58% | -9.2 points |
REBN's operating margin was −25% last quarter, up 215 points from the same quarter a year ago.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with REBN at down 42%.
REBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.7M | -$1.1M |
| Q3 2025 | -$1.6M | -$1.2M |
| Q4 2024 | -$600.9K | +$1.3M |
| Q3 2024 | -$424K | -114% |
| Q2 2024 | -$615.9K | +$4M |
| Q1 2024 | -$2.9M | -$786.7K |
| Q4 2023 | -$1.9M | -$206.3K |
| Q3 2023 | $3M | +$3.9M |
REBN has burned cash in almost every quarter: −$5M over the past year, against −$5M the year before.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has the edge over REBN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
REBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +78% | +3.6M shares |
| 3 years | +440% | +6.7M shares |
REBN has 8M diluted shares, up 78% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
REBN Net Leverage
REBN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
REBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.7 | Neutral |
| Stochastic | 38.7 | Neutral |
REBN's weekly RSI is 43 (neutral) and its Stochastic is 39 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
REBN PE vs Consumer Cyclical Sector
REBN has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
REBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.54 | 32% below |
| 20 week MA | $1.37 | 23% below |
| 50 week MA | $1.69 | 38% below |
| 100 week MA | $2.21 | 52% below |
| 200 week MA | $3.34 | 69% below |
REBN is in a downtrend: it's below all five of its weekly moving averages, and 69% below its 200-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
REBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $38.4 | $6.24 | -84% |
| 2023 | $6.24 | $4.56 | -27% |
| 2024 | $4.56 | $1.80 | -61% |
| 2025 | $1.80 | $1.47 | -18% |
| 2026 YTD | $1.47 | $1.05 | -29% |
REBN has the edge over NIO on returns for 2026, with the stronger performance.